GlassScriptPhysician profile
Brett J Cassidy
NPI 1649256975
$114,089.60
in general payments reported to CMS, 2019-2025
23 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $13K · 2021: $43K · 2022: $26K · 2023: $245 · 2024: $73.21 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14,000.00 |
| Food and Beverage | $932.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $112,017.79 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $803.66 | 2019-2022 | |
| Coopersurgical, INC. | $305.51 | 2019-2023 | Summit Doppler |
| Aspira Women'S Health INC | $192.85 | 2021-2022 | |
| Hologic Sales and Service, LLC | $100.79 | 2019-2023 | Myosure Tissue Removal Device, Acessa Provu System |
| Mayne Pharma Commercial LLC | $92.52 | 2022-2023 | |
| Angiodynamics, INC. | $84.70 | 2019-2022 | |
| Bard Access Systems, INC. | $72.76 | 2019 | |
| Avion Pharmaceuticals | $68.98 | 2020-2021 | |
| Exeltis, USA INC. | $63.86 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $48.27 | 2024 | Veozah |
| Allergan, INC. | $37.86 | 2019 | |
| Conmed Corporation | $29.41 | 2022 | |
| Pfizer INC. | $24.94 | 2024 | |
| Myovant Sciences INC. | $20.20 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $19.92 | 2019 | |
| Merz North America, INC. | $18.44 | 2022 | |
| Therapeuticsmd, INC. | $18.20 | 2019 | |
| Meditrina | $16.77 | 2023 | |
| Dysis Medical, INC. | $15.60 | 2020 | |
| Evofem Biosciences, INC. | $13.79 | 2022 | |
| Agile Therapeutics, INC. | $11.49 | 2021 | |
| Minerva Surgical, INC | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Cassidy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.